Resultados da pesquisa - brain ((((tumor res) OR (tumor rates))) or (((tumor cures) or (tumor cure)))) treat

Pesquisas alternativas:
tumor rates » tumour rates (Expandir a Pesquisa), tumor rate (Expandir a Pesquisa), tumor states (Expandir a Pesquisa)
tumor cures » tumor cured (Expandir a Pesquisa), tumor causes (Expandir a Pesquisa), tumour cured (Expandir a Pesquisa)
tumor cure » tumor care (Expandir a Pesquisa), tumor case (Expandir a Pesquisa), tumor car (Expandir a Pesquisa)
tumor res » tumor re (Expandir a Pesquisa), tumor ras (Expandir a Pesquisa), tumor red (Expandir a Pesquisa)

1

Management of children with brain tumors in Paraguay

Management of children with brain tumors in Paraguay

Por Baskin, Jacquelyn L., Lezcano, Eva, Kim, Bo Sung, Figueredo, Diego, Lassaletta, Alvaro, Perez-Martinez, Antonio, Madero, Luis, Caniza, Miguela A., Howard, Scott C., Samudio, Angelica, Finlay, Jonathan L.
Publicado em 2013

“...BACKGROUND: Cure rates among children with brain tumors differ between low-income and high-income...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

HGG-39. EFFECT OF TUMOR TREATING FIELDS IN CHILDREN WITH RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA AND EPENDYMOMA (PEDIATRIC BRAIN TUMOR CONSORTIUM PBTC048)

HGG-39. EFFECT OF TUMOR TREATING FIELDS IN CHILDREN WITH RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA AND EPENDYMOMA (PEDIATRIC BRAIN TUMOR CONSORTIUM PBTC048)

Por Goldman, Stewart
Publicado no Neuro Oncol (2018)

“... (OS) of pediatric recurrent/progressive ependymoma is also poor. Tumor Treating Fields (TTFields...”
Obter o texto integral
Obter o texto integral

Artigo

3

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss

Por Sampson, John H., Choi, Bryan D., Sanchez-Perez, Luis, Suryadevara, Carter M., Snyder, David J., Flores, Catherine T., Schmittling, Robert J., Nair, Smita, Reap, Elizabeth A., Norberg, Pamela K., Herndon, James E., Kuan, Chien-Tsun, Morgan, Richard A., Rosenberg, Steven A., Johnson, Laura A.
Publicado em 2013

“... in all mice with brain tumors. Additionally, antitumor efficacy was found to be dependent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

TMIC-15. OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL

TMIC-15. OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES...

Por Le Moan, Natacha, Davis, Tina, Leung, Philberta, Ng, Sarah, Winger, Jonathan, Cary, Stephen, Butowski, Nicholas, Krtolica, Ana
Publicado no Neuro Oncol (2018)

“... microenvironment and promote tumor cures. RESULTS: Following intravenous administration in brain tumor-bearing mice...”
Obter o texto integral
Obter o texto integral

Artigo

5

Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors

Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors

Por Yang, Weilian, Barth, Rolf F, Huo, Tianyao, Nakkula, Robin J, Weldon, Michael, Gupta, Nilendu, Agius, Lawrence, Grecula, John C
Publicado em 2014

“... with a mean survival time (MST) of 107.7 d and a 43% cure rate vs. 83.6 d with CED vs. 30-35 d for RT...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors

Por Endersby, Raelene, Whitehouse, Jacqueline, Hii, Hilary, Greenall, Sameer A., Johns, Terrance G., Gottardo, Nicholas G.
Publicado no Neoplasia (2018)

“..., are aggressive brain tumors. The survival for patients with glioblastoma remains dismal. While the cure rate...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers

Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers

Por MIMEAULT, M., BATRA, S.K.
Publicado em 2008

“... tumors and epithelial cancers are the devastating diseases associated with a high rate of recurrence...”
Obter o texto integral
Obter o texto integral

Artigo

8

Comparing proton treatment plans of pediatric brain tumors in two pencil beam scanning nozzles with different spot sizes

Comparing proton treatment plans of pediatric brain tumors in two pencil beam scanning nozzles with different spot sizes

Por Kralik, John C., Xi, Liwen, Solberg, Timothy D., Simone, Charles B., Lin, Liyong
Publicado no J Appl Clin Med Phys (2015)

“... brain tumor types having high cure rates, this study suggests the smaller DN beam profile is preferable...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors

Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors

Por Wu, Yushui, Lun, Xueqing, Zhou, Hongyuan, Wang, Limei, Sun, Beichen, Bell, John C., Barrett, John W., McFadden, Grant, Biegel, Jaclyn A., Senger, Donna L., Forsyth, Peter A.
Publicado em 2008

“...). Most of the MV-treated animals (4 of 6; 66.7%) were alive and apparently “cured” when the experiment...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34

Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors...

Por Strother, Douglas R., Lafay-Cousin, Lucie, Boyett, James M., Burger, Peter, Aronin, Patricia, Constine, Louis, Duffner, Patricia, Kocak, Mehmet, Kun, Larry E., Horowitz, Marc E., Gajjar, Amar
Publicado em 2014

“... with newly diagnosed malignant brain tumors. METHODS: Of 328 enrolled eligible patients, diagnoses were...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

P11.08 Systematic drug repurposing for faster cures of pediatric cancer identifies that Digoxin prolongs survival in a PDOX model of group 4 medulloblastoma

P11.08 Systematic drug repurposing for faster cures of pediatric cancer identifies that Digoxin prolongs survival in a PDOX model of group 4 medulloblastoma

Por Huang, L., Injac, S. G., Zhao, H., Lin, Q., Kogiso, M., Man, C., Li, X., Lau, C., Wong, S. T. C.
Publicado no Neuro Oncol (2017)

“...Background: Medulloblastoma (MB) is the most common malignant brain tumor of childhood. While...”
Obter o texto integral
Obter o texto integral

Artigo

12

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas

An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas

Por Murphy, Katherine A., Lechner, Melissa G., Popescu, Flavia E., Bedi, Jessica, Decker, Stacy A., Hu, Peisheng, Erickson, Jami R., O’Sullivan, M. Gerard, Swier, Lauryn, Salazar, Andres M., Olin, Michael R., Epstein, Alan L., Ohlfest, John R.
Publicado em 2012

“... portion of human immunoglobulin. Lymphocytes and mRNA were purified from the brain tumor site for immune...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Primary Intracranial Fibrosarcoma Presenting with Hemorrhage

Primary Intracranial Fibrosarcoma Presenting with Hemorrhage

Por Lee, Jong Gon, Song, Sang Woo, Koh, Young-Cho, Cho, Joon, Choi, Jin Woo, Roh, Hong Gee, Lim, So-Dug
Publicado em 2013

“...Primary intracranial fibrosarcomas (PIFs) are extremely rare and the origin of these tumors...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Targeting Notch signalling pathway of cancer stem cells

Targeting Notch signalling pathway of cancer stem cells

Por Venkatesh, Vandana, Nataraj, Raghu, Thangaraj, Gopenath S., Karthikeyan, Murugesan, Gnanasekaran, Ashok, Kaginelli, Shanmukhappa B., Kuppanna, Gobianand, Kallappa, Chandrashekrappa Gowdru, Basalingappa, Kanthesh M.
Publicado no Stem Cell Investig (2018)

“...Cancer stem cells (CSCs) have been defined as cells within tumor that possess the capacity to self...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide

Por Braga, Antonio, Mora, Paulo, de Melo, Andréia Cristina, Nogueira-Rodrigues, Angélica, Amim-Junior, Joffre, Rezende-Filho, Jorge, Seckl, Michael J
Publicado no World J Clin Oncol (2019)

“..., but, if treated in reference centers, has high cure rates, even in multi-metastatic cases. The diagnosis of GTN...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy

Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy

Por Crawford, Sarah
Publicado em 2013

“... survival for some of the most common cancers, including tumors of the lung, colon breast, brain, melanoma...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

MBCL-18. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

MBCL-18. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

Por Shah, Nidhi, Walter, Andrew
Publicado no Neuro Oncol (2018)

“..., including surgery, chemotherapy and radiation therapy in standard-risk medulloblastoma has led to cure rates...”
Obter o texto integral
Obter o texto integral

Artigo

18

PATH-56. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

PATH-56. CHEK2 MUTATION IN HIGH-RISK MEDULLOBLASTOMA

Por Shah, Nidhi, Walter, Andrew
Publicado no Neuro Oncol (2018)

“..., including surgery, chemotherapy and radiation therapy in standard-risk medulloblastoma has led to cure rates...”
Obter o texto integral
Obter o texto integral

Artigo

19

DDIS-23. A COMBINATORIAL TREATMENT USING A CK2 INHIBITOR, CX-4945, AND TMZ DECREASED MEDULLOBLASTOMA TUMORIGENESIS

DDIS-23. A COMBINATORIAL TREATMENT USING A CK2 INHIBITOR, CX-4945, AND TMZ DECREASED MEDULLOBLASTOMA TUMORIGENESIS

Por Nitta, Ryan, Nwagbo, Gigi, Jin, Benjamin, Li, Gordon
Publicado no Neuro Oncol (2017)

“...Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While surgery...”
Obter o texto integral
Obter o texto integral

Artigo

20

Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas

Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas

Por Godfraind, Catherine, Kaczmarska, Joanna M., Kocak, Mehmet, Dalton, James, Wright, Karen D., Sanford, Robert A., Boop, Fredrick A., Gajjar, Amar J., Merchant, Thomas E., Ellison, David W.
Publicado em 2012

“... of maximal cure rates and minimal adverse therapeutic effects. This study examined associations between...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo